Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2021
The objective of this study is to evaluate the safety and effectiveness of OC-01 (varenicline) nasal spray as compared to placebo nasal spray for mean change from baseline in corneal fluorescein staining in subjects with Stage 1 (corneal epithelial hyperplasia/punctate keratopathy) neurotrophic keratopathy (NK) in one or both eyes.
Epistemonikos ID: 1459687d2e5fc88de5ee3db93574d3bbb54633cc
First added on: Dec 20, 2022